Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
letter
. 2004 Jul;63(7):896.

Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy

J Gomez-Puerta, R Sanmarti, J Rodriguez-Cros, J Canete
PMCID: PMC1755079  PMID: 15194598

Full Text

The Full Text of this article is available as a PDF (48.7 KB).

Figure 1.

Figure 1

 Disease activity according to DAS28 in 12 patients with RA treated with infliximab and switched to etanercept. Mean DAS values are shown for infliximab (INF; baseline, 6 weeks of treatment, last infusion) and etanercept (ETC; baseline, 3 and 6 months of treatment). Comparison was made using a non-parametric test (Wilcoxon). m, months; w, weeks.


Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES